Skip to main content
Top
Published in: Rheumatology International 7/2019

01-07-2019 | Ankylosing Spondylitis | Public Health

Does YouTube provide high quality information? Assessment of secukinumab videos

Authors: Burhan Fatih Kocyigit, Mazlum Serdar Akaltun

Published in: Rheumatology International | Issue 7/2019

Login to get access

Abstract

The Internet is a widely used source for obtaining health-related information. With the widespread use of the Internet, access to information has become easier. YouTube is one of the major sources for health-related videos globally. YouTube provides a wide range of health-related information, but there are doubts about its quality and reliability. Therefore, we aimed to assess the quality of the most viewed secukinumab videos on YouTube. This is a descriptive study. A total of 180 secukinumab videos returned by the YouTube search engine (http://​www.​youtube.​com) in response to a keywords query were evaluated in the study. The Global Quality Scale (GQS) was used to assess educational quality, and three groups were created: high quality, intermediate quality, and low quality. Video parameters were compared among the quality groups. After applying the exclusion criteria, 53 videos were analyzed; 18 (34%) videos were in the high-quality group, 17 (32%) were in the intermediate-quality group, and 18 (34%) were in the low-quality group. No significant difference was detected in terms of the number of views, likes, dislikes, and comments per day between the groups (p > 0.05). YouTube has a mixed structure of high, intermediate, and low-quality videos. The number of views, likes, dislikes, and comments per day should not be accepted as an indicator of quality for YouTube videos. In addition, patients should consider the importance of sources when obtaining online health-related information.
Literature
1.
2.
go back to reference Langley RG, Elewski BE, Lebwohl M, Reich K, Griffiths CE, Papp K, Puig L, Nakagawa H, Spelman L, Sigurgeirsson B, Rivas E, Tsai TF, Wasel N, Tyring S, Salko T, Hampele I, Notter M, Karpov A, Helou S, Papavassilis C, ERASURE Study Group; FIXTURE Study Group (2014) Secukinumab in plaque psoriasis—results of two phase 3 trials. N Engl J Med 371:326–338. https://doi.org/10.1056/NEJMoa1314258 CrossRefPubMed Langley RG, Elewski BE, Lebwohl M, Reich K, Griffiths CE, Papp K, Puig L, Nakagawa H, Spelman L, Sigurgeirsson B, Rivas E, Tsai TF, Wasel N, Tyring S, Salko T, Hampele I, Notter M, Karpov A, Helou S, Papavassilis C, ERASURE Study Group; FIXTURE Study Group (2014) Secukinumab in plaque psoriasis—results of two phase 3 trials. N Engl J Med 371:326–338. https://​doi.​org/​10.​1056/​NEJMoa1314258 CrossRefPubMed
3.
go back to reference Baeten D, Baraliakos X, Braun J, Sieper J, Emery P, van der Heijde D, McInnes I, van Laar JM, Landewé R, Wordsworth P, Wollenhaupt J, Kellner H, Paramarta J, Wei J, Brachat A, Bek S, Laurent D, Li Y, Wang YA, Bertolino AP, Gsteiger S, Wright AM, Hueber W (2013) Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial. Lancet 382:1705–1713. https://doi.org/10.1016/S0140-6736(13)61134-4 CrossRefPubMed Baeten D, Baraliakos X, Braun J, Sieper J, Emery P, van der Heijde D, McInnes I, van Laar JM, Landewé R, Wordsworth P, Wollenhaupt J, Kellner H, Paramarta J, Wei J, Brachat A, Bek S, Laurent D, Li Y, Wang YA, Bertolino AP, Gsteiger S, Wright AM, Hueber W (2013) Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial. Lancet 382:1705–1713. https://​doi.​org/​10.​1016/​S0140-6736(13)61134-4 CrossRefPubMed
9.
go back to reference Bernard A, Langille M, Hughes S, Rose C, Leddin D, Veldhuyzen van Zanten S (2007) A systematic review of patient inflammatory bowel disease information resources on the world wide web. Am J Gastroenterol 102:2070–2077CrossRefPubMed Bernard A, Langille M, Hughes S, Rose C, Leddin D, Veldhuyzen van Zanten S (2007) A systematic review of patient inflammatory bowel disease information resources on the world wide web. Am J Gastroenterol 102:2070–2077CrossRefPubMed
10.
go back to reference Charnock D, Shepperd S, Needham G, Gann R (1999) DISCERN: an instrument for judging the quality of written consumer health information on treatment choices. J Epidemiol Community Health 53:105–111CrossRefPubMedPubMedCentral Charnock D, Shepperd S, Needham G, Gann R (1999) DISCERN: an instrument for judging the quality of written consumer health information on treatment choices. J Epidemiol Community Health 53:105–111CrossRefPubMedPubMedCentral
16.
go back to reference Erdem MN, Karaca S (2018) Evaluating the accuracy and quality of the information in kyphosis videos shared on YouTube. Spine (Phila Pa 1976) 43:E1334–E1339CrossRef Erdem MN, Karaca S (2018) Evaluating the accuracy and quality of the information in kyphosis videos shared on YouTube. Spine (Phila Pa 1976) 43:E1334–E1339CrossRef
Metadata
Title
Does YouTube provide high quality information? Assessment of secukinumab videos
Authors
Burhan Fatih Kocyigit
Mazlum Serdar Akaltun
Publication date
01-07-2019
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 7/2019
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-019-04322-8

Other articles of this Issue 7/2019

Rheumatology International 7/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.